Description
Retatrutide 20mg – Triple Agonist for Advanced Weight Loss & Metabolic Research
Retatrutide 20mg is a next-generation multi-receptor agonist designed to support substantial weight reduction and metabolic health optimization. By simultaneously activating GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, Retatrutide offers a triple-action mechanism that helps regulate appetite, enhance insulin sensitivity, increase fat oxidation, and stabilize blood glucose levels.
This 20mg formulation is typically evaluated in advanced research protocols where a higher therapeutic threshold is being studied for its potential impact on obesity, insulin resistance, and energy balance.
Key Features:
-
20mg high-purity Retatrutide peptide
-
Triple agonist: GLP-1, GIP, and glucagon receptor activation
-
Promotes weight loss, appetite suppression, and fat metabolism
-
Enhances insulin sensitivity and glycemic control
-
Ideal for advanced metabolic and obesity-related research
⚠️ For Research Use Only. Not for Human Consumption.
This compound is sold strictly for in vitro laboratory research purposes only. It is not intended for human or veterinary use, nor for diagnostic or therapeutic purposes. No claims are made regarding safety or efficacy in any clinical application.Disclaimer:
All information provided is for educational and scientific reference only. Statements have not been evaluated by the FDA or any medical regulatory body. This product is not a drug or supplement. Buyer assumes all responsibility for lawful use and compliance with applicable regulations.Terms of Sale:
By purchasing from LIBERTY LABS, you confirm that you are a qualified researcher or institution equipped to handle this material safely. You accept full responsibility for its use and understand that Liberty Labs assumes no liability for misuse, misinterpretation, or improper application of this compound. ALL SALES FINAL